Business
1st Glaucoma Trial Completion
1st Glaucoma Trial Completion.
About this update from Seeing Machines Limited
[{"type":"text","content":"\n Seeing Machines Limited\n10 January 2006\n\n\n\n10 January 2006\n\n SEEING MACHINES LIMITED\n\n ('Seeing Machines' or 'the Company')\n\n\n\n NON -CONTACT OBJECTIVE GLAUCOMA DEVICE SUCCESSFULLY COMPLETES\n\n FIRST MAJOR CLINICAL TRIAL\n\n\n\nSeeing Machines Limited (AIM : SEE), a leading developer of advanced computer\nbased imaging software systems, announces the completion of the first major\nclinical trial of its new groundbreaking technology for objective detection and\nmanagement of glaucoma, the group of eye diseases that affect peripheral vision,\noften leading to permanent loss of vision.\n\nSeeing Machines is developing a new medical device that assists clinicians to\ndiagnose and manage disorders of the human visual system, particularly glaucoma.\n This recent trial has demonstrated with meaningful clinical utility, that the\ntechnology, as it stands today:\n\n• successfully detects the loss of visual field associated with\nglaucoma, and\n\n• successfully differentiates between those patients with visual field\nloss and those without, thus providing the basis for a reliable and accurate\ndiagnostic instrument.\n\nFurthermore the trial has demonstrated significant opportunities for greatly\nimproving the performance of the technology from the base-line used in this\ntrial.\n\nCommenting on the trial, Nick Cerneaz, Chief Executive of Seeing Machines said:\n\n'The technical progress demonstrated in this trial has assisted Seeing Machines\nin reaching a key milestone of our entire medical device development program.\nOur scientific teams, led by Drs. Ted Maddess and Andrew James from the\nAustralian National University, have done a tremendous job so far and we are now\nwell advanced in the development work arising from this trial. The preparations\nfor the next major clinical trial aimed at testing these developments are well\nunderway with an anticipated start date this quarter. We are very excited about\nthese results and keen to build further on them as we pursue our goal of\ndelivering the world's first non-contact objective test for glaucoma.'\n\n\n\nEnquiries:\nSeeing Machines Limited Insinger de Beaufort Parkgreen Communications\nNick Cerneaz, CEO Simon Fox Justine Howarth /\n\n Victoria Thomas\n+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713\nwww.seeingmachines.com\n\n\n\n\n This information is ...